Welcome to our dedicated page for Unitedhealth Gp SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
UnitedHealth Group Incorporated (UNH) provides extensive disclosure to investors and regulators through its SEC filings, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents offer a detailed view of the company’s health care and well-being operations, which span UnitedHealthcare’s health benefit programs and Optum’s health services, technology and analytics businesses.
Annual and quarterly reports describe UnitedHealth Group’s consolidated financial condition and results of operations, as well as segment performance for UnitedHealthcare and Optum. They include information on revenues, earnings from operations, medical costs, operating costs, cash flows, capital structure and risk factors. Investors use these filings to understand how trends in medical utilization, Medicare and Medicaid funding, and pharmacy services affect the company’s financial profile.
Current reports on Form 8-K provide timely updates on material events. Recent 8-K filings have covered topics such as quarterly earnings releases, reaffirmation of earnings outlooks, amendments to bylaws to reflect changes in the company’s registered office and registered agent in Delaware, the appointment of new independent directors, and investor presentations. Some 8-K items are furnished under Regulation FD to share information discussed with investors and analysts, including earnings expectations and the impact of acquisitions like Amedisys.
UnitedHealth Group also files 8-Ks to document governance and leadership changes, including the appointment of directors with regulatory and clinical backgrounds. These filings often reference standard indemnification agreements and compensation arrangements for non-employee directors, providing additional transparency into board practices.
On this SEC filings page, users can review UnitedHealth Group’s regulatory disclosures in one place. Real-time updates from EDGAR ensure that new 10-K, 10-Q and 8-K filings, as well as any amendments, appear promptly. AI-powered summaries can help explain complex sections, highlight key metrics, and clarify the implications of items such as changes in outlook, medical cost trends or bylaw amendments. Investors can also monitor executive and director changes reported on Form 8-K and use the filings history to track how UnitedHealth Group’s strategy, capital management and risk profile evolve over time.
UnitedHealth Group CEO and director Stephen J. Hemsley reported a gift of company stock. On 12/19/2025, he conveyed 55,000 shares of UnitedHealth Group common stock as a gift at a reported price of $0. After this transaction, he beneficially owned 372,947.942 shares directly. He also held 351.9396 shares indirectly through a 401(k) plan and 681,875 shares indirectly through trusts. The filing indicates this was a personal share transfer rather than an open‑market sale.
UnitedHealth Group executive reports routine share accrual from dividends. Timothy J. Noel, Chief Executive Officer of UnitedHealthcare (a unit of UnitedHealth Group Inc.), reported acquiring 44.329 shares of UnitedHealth Group common stock on 12/16/2025. The filing explains this represents dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying awards and are forfeited if those units do not vest.
These shares were acquired at a price of $0, reflecting that they are dividend-related accruals rather than open-market purchases. Following this transaction, Noel directly beneficially owns 9,330.668 shares of UnitedHealth Group common stock.
UnitedHealth Group director reports stock credited from dividend equivalents. On 12/16/2025, a director of UnitedHealth Group Inc. received 43 shares of common stock at a price of $0. These shares represent dividend equivalents paid on vested deferred stock units, and are immediately vested under the same terms as the underlying deferred stock units.
Following this transaction, the director beneficially owns 6,940 shares of UnitedHealth Group common stock in direct form.
UnitedHealth Group executive reports routine share accrual tied to awards
UnitedHealth Group executive Erin L. McSweeney, EVP & Chief People Officer, reported an acquisition of 38.566 shares of UnitedHealth Group common stock on 12/16/2025. The filing explains that this amount represents dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying awards and are forfeited if those units do not vest. After this transaction, McSweeney beneficially owned a total of 11,192.638 shares of common stock in direct form.
UnitedHealth Group director reports receipt of dividend equivalents in stock. A director of UnitedHealth Group Inc. received 11 shares of common stock on 12/16/2025 at a reported price of $0. The filing explains that these shares represent dividend equivalents paid on vested deferred stock units, and that the dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units. Following this transaction, the director beneficially owns 1,527 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group CEO and director Stephen J. Hemsley reported a routine insider transaction involving dividend equivalents on his deferred stock units. On 12/16/2025, he acquired 52 shares of common stock at a price of $0, reflecting dividend equivalents that are immediately vested and subject to the same terms as the underlying deferred stock units.
Following this transaction, Hemsley beneficially owns 427,947.942 shares of UnitedHealth Group common stock directly. He also reports indirect ownership of 351.9396 shares through a 401(k) and 681,875 shares through trusts. The filing reflects an incremental increase tied to existing equity compensation rather than an open-market purchase.
UnitedHealth Group director reports small stock accrual from dividends
A UnitedHealth Group Inc. director, Frederick William McNabb III, reported receiving 53 shares of UnitedHealth Group common stock on 12/16/2025. The filing states these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. The transaction was recorded at a price of $0 per share, reflecting that no cash was paid by the director for these shares.
Following this transaction, the director beneficially owns 14,394 shares of UnitedHealth Group common stock in direct ownership. The form was filed as a single-reporting-person Form 4 and signed by an attorney-in-fact on behalf of the director.
UnitedHealth Group director John H. Noseworthy, M.D. reported a small increase in his holdings of UnitedHealth Group common stock. On 12/16/2025, he acquired 43 shares at a price of $0, described as dividend equivalents paid on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units. Following this transaction, he beneficially owns 6,736 shares of UnitedHealth Group common stock in direct ownership.
UnitedHealth Group director Kristen L. Gil reported a small change in her holdings of UnitedHealth Group common stock. On 12/16/2025, she acquired 7 shares of common stock at a price of $0, recorded as dividend equivalents paid on vested deferred stock units. After this transaction, she beneficially owned 1,907 shares directly and 3,800 shares indirectly through a trust. The dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units.
UnitedHealth Group executive Christopher R. Zaetta, EVP & Chief Legal Officer, reported acquiring additional UnitedHealth Group common stock through dividend equivalents on restricted stock units. On 12/16/2025, he acquired 44.528 shares at a price of $0, reflecting reinvested dividends rather than an open-market purchase. These dividend equivalents are subject to the same vesting conditions as the underlying restricted stock units and are forfeited if those units do not vest. Following this transaction, Zaetta beneficially owns 10,327.804 shares of UnitedHealth Group common stock in direct ownership.
FAQ
What is the current stock price of Unitedhealth Gp (UNH)?
What is the market cap of Unitedhealth Gp (UNH)?
